How to submit comments and questions for each exam question
This activity is intended for endocrine fellows planning for initial certification, practicing endocrinologists preparing for an MOC assessment, or physicians seeking an in-depth review of endocrinology. The secondary target audience includes advanced practice nurses and physician assistants.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates Endocrine Board Review 2024 Virtual Meeting for a maximum of 55 AMA PRA Category 1 Credits™ and 55 points in the ABIM Maintenance of Certification (MOC) program. Successful completion of this CME activity includes participation in the activity evaluation. After completing the activity evaluation, participants will be able to save or print a CME certificate. It is the CME activity provider’s responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC points.
CME credits and/or MOC points for the activities related to this material must be claimed by December 31, 2024.
AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 55 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.
Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.
Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 55 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For questions about content or obtaining CME credit, please contact the Endocrine Society at eventeducation@endocrine.org
Frances J. Hayes, MB BCh BAO - Program Chair
Associate Chief for Clinic and Education of the Reproductive Endocrine
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
John D. Carmichael, MD
Clinical Chief
Division of Endocrinology, Diabetes, and Metabolism
Co-Director, USC Pituitary Center
Associate Professor of Clinical Medicine
Keck School of Medicine of the University of Southern California
Natalie Cusano, MD, MS
Associate Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Director of the Bone Metabolism Program
Division of Endocrinology at Lenox Hill Hospital
Kanishka Desai, MD
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Stanford University
Tobias Else, MD
Associate Professor of Internal Medicine
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan
Jacqueline Jonklaas, MD, PhD, MPH
Professor
Division of Endocrinology
Georgetown University Medical Center
Sangeeta R. Kashyap, MD
Assistant Chief of Clinical Affairs
Division of Endocrinology, Diabetes and Metabolism
Weill Cornell Medicine New York Presbyterian
Margaret Flynn Lippincott, MD
Assistant Professor of Medicine
Harvard Medical School
Physician Investigator
Reproductive Endocrine Unit
Massachusetts General Hospital
Marie E. McDonnell, MD
Chief, Diabetes Section
Division of Endocrinology Diabetes and Hypertension
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Stephanie T. Page, MD, PhD
Professor/Head, Division of Metabolism, Endocrinology, and Nutrition
Co-Director, UW Medicine Diabetes Institute
Robert B. McMillen Professor of Medicine in Lipid Research
University of Washington School of Medicine
Anne L. Peters, MD
Professor of Clinical Medicine
Keck School of Medicine of the University of Southern California
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
John D. Carmichael, MD, has served as an advisory board member for Camurus, Novo Nordisk, Recordati, and Xeris. He is also a member of the American Association of Clinical Endocrinologists (Pituitary, Adrenal, and Neuroendocrine Disease State Network) and the Pituitary Society.
Natalie E. Cusano, MD, MS, has served as a research investigator for Shire/Takeda, a speaker for Alexion Pharmaceuticals, and a consultant for Ascendis Pharma. She has also spoken for Alexion and serves on the Editorial Board for Endocrine Practice.
Tobias Else, MD, has served as a co-investigator for Corcept Pharmaceuticals and Merck; an advisory board member for Merck and Lantheus; and a committee member for VHL Alliance.
Sangeeta R. Kashyap, MD, has served as a consultant and coinvestigator to GI Dynamics; she has received research support from Fractyl, Inc; and she is chief medical officer of Gila Therapeutics.
Marie E. McDonnell, MD, has served as a trial event adjudicator for a trial conducted by Eisai and receives research funding from Lilly, Inc, that is paid to her institution.
Stephanie Page, MD, PhD, is an editor at UpToDate and has served as a consultant to Pharmajor International.
Anne L. Peters, MD, has served as an advisory board member for Abbott Diabetes Care, Medscape, Novo Nordisk, Vertex, and Zealand and as a consultant for Blue Circle Health. She has received research support from Dexcom, Insulet, and Abbott Diabetes Care. She has stock options in Omada Health and Teladoc.
The following faculty reported no relevant financial relationships: Kaniksha Desai, MD; Frances J. Hayes, MB BCh, BAO; Jacqueline Jonklaas, MD, PhD, MPH; and Margaret Flynn Lippincott, MD
The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
The activity is not supported by educational grant(s) or other funds from any commercial supporters.